Polycationic Amphiphiles Eradicate Resistant Biofilms
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antimicrobial compounds face challenges in effectively inhibiting or eradicating biofilms, particularly pre-established ones, due to bacterial resistance and the complexity of biofilm matrices, which interfere with antibiotic localization and disrupt traditional molecular targets.
Innovation Solution
Development of polycationic amphiphiles, such as triscationic and tetracationic compounds with specific alkyl and functional group substitutions, that can disrupt biofilms by interacting with bacterial cell membranes and eradicating biofilms at low micromolar concentrations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional antibiotics are used, then bacterial infections can be treated, but bacterial resistance develops and biofilms are not effectively eradicated
Solution Approach 1:
The patent changes the chemical parameters of antimicrobial compounds by developing polycationic amphiphiles with multiple cationic charges (triscationic or tetracationic) and specific amphiphilic structures. These structural parameter changes enable the compounds to disrupt biofilm matrices and bacterial membranes more effectively than traditional antibiotics, overcoming resistance mechanisms while maintaining antimicrobial effectiveness.
Solution Approach 2:
The patent employs composite molecular structures combining multiple cationic functional groups with hydrophobic and hydrophilic regions in a single amphiphilic molecule. This composite structure allows simultaneous interaction with both the hydrophobic bacterial membrane and hydrophilic biofilm matrix components, achieving broad-spectrum activity against resistant bacteria and biofilms.
2Reliability
If high concentrations of antimicrobial agents are used, then biofilm eradication is improved, but toxicity and side effects increase
Solution Approach 1:
The patent optimizes the concentration parameter by demonstrating that polycationic amphiphiles achieve effective biofilm eradication at low micromolar concentrations (significantly lower than traditional antimicrobials). The enhanced potency per unit concentration is attributed to the multiple cationic charges and amphiphilic structure that facilitate deep penetration into biofilm matrices and direct membrane disruption, reducing the need for high dosing and associated toxicity.
3Ease of operation
If conventional antimicrobial compounds are used, then simple bacterial infections can be treated, but pre-established biofilms remain resistant due to matrix interference
Solution Approach 1:
The patent changes the molecular charge parameter by incorporating multiple cationic groups (triscationic or tetracationic) into the amphiphilic structure. These positively charged groups interact electrostatically with the negatively charged components of the biofilm matrix (such as extracellular polymeric substances and bacterial surfaces), enabling the compounds to penetrate and disrupt pre-established biofilms that are resistant to conventional neutral or singly-charged antimicrobials.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The polycationic amphiphiles demonstrate potent antibiofilm activity, achieving significant biofilm eradication at low concentrations, with compounds like (12,2,1,2,12) and (12,3,1,3,12) showing remarkable effectiveness against Staphylococcus aureus and Enterococcus faecalis biofilms, offering a novel approach to combat resistant biofilm infections.
Implementation Method 1
polycationic amphiphiles, such as triscationic or tetracationic compounds with specific alkyl and functional group substitutions, that can disrupt biofilms by interacting with bacterial cell membranes
Data Source
AI summary
The present disclosure provides an antimicrobial composition including a polycationic amphiphile compound, and the method of making and the method of using such a compound or composition. The compound having the formulaR1, R2, R3, R4, R5, R6, R10, or R11 is H or a C1-12 alkyl unsubstituted or optionally substituted with a functional group such as —OH, —OR′, —NH2, —NHR′, —NR′2, —N—C(O)R′, —N—C(O)CR′═CR′, —SH, —SR′, —O—C(O)R′, —C(O)R′, —CF3, —OCF3, halogen, benzyl, o-vinylbenzyl, m-vinylbenzyl, p-vinylbenzyl, phenyl, allyl, and substituted allyl. R7, R8 or R9 is a C1-12 alkyl unsubstituted or optionally substituted with a functional group such as —OH, —OR′, —NH2, —NHR′, —SH, —SR′, —O—C(O)R′, —C(O)R′, —CF3, and —OCF3. R′ is H or a C1-4 alkyl. X or Y is a halogen. m and n are integers in the range from 1 to 25.